Table 1 The overall scopes of the subjects and the provisions corresponding to the framework
| AUSFTA | KORUS | TPP | |||
|---|---|---|---|---|---|
| Signed / Implemented year | 2004 / 2005 | 2007 / 2012 | 2018 / 2018 | ||
| Subjects | Annex 2-C - Pharmaceuticals | Side letters PBS | Chapter 5 – Pharmaceutical products and medical devices | Chapter 26 – Transparency and Anticorruption | Annex 26-A Transparency and Procedural Fairness for Pharmaceutical Products and Medical Devices |
| Composition | 6 provisions and 580 words | 4 provisions and 251 words | 8 provisions and 1731 words |
3 sections (definitions, transparency, anti-corruption), 12 provisions, 3136 words | 5 provisions and 2072 words |
| Principles | 1: Agreed Principles | 1: General provisions | – | 2: Principles | |
|
Value for money (innovation) | – | 2: Access to innovation | – | – | |
| Transparency | 2: Transparency | 4 provisions are related with transparency | 3: Transparency |
2: Publication 3: Administrative Proceedings 4: Review and Appeal 5: Provision of Information | 3: Procedural Fairness |
| Others |
3: Medicines Working Group 4: Regulatory Cooperation 5: Dissemination of Information 6: Definitions |
4: Dissemination of Information 5: Ethical Business Practices 6: Regulatory Cooperation 7: Medicines and medical devices committee 8: Definitions | 1: Definitions |
1: Definitions 4: Dissemination of Information to Health Professionals and Consumers 5: Consultation | |